LMG Life Sciences Awards 2019 – shortlists announced
July 19, 2019
Ceremony will take place on Sept. 18 at Essex House in New York
US
Patent Prosecution
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Bookoff, Les | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Washington, D.C. |
| McAndrews, Roland | Intellectual Property | Patent Strategy & Management | Washington, D.C. |
| Melwani, Dinesh | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Washington, D.C. |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Bookoff McAndrews
Bookoff McAndrews is an IP firm focused on patent prosecution and counseling, most notably for companies in the medical device sector. Since its founding six years ago, the firm has grown in number of attorneys and life sciences clients, one of whom says: "The firm provides excellent service across all IP requirements in the life sciences sector." While the firm is noteworthy for its work in the device area, it has shown significant activity in the biotechnology and pharmaceutical fields as well.
Founding partners Les Bookoff and Roland McAndrews offer a combined 50 years of experience in the patent field, and have backgrounds at a global IP firm. A client says about Bookoff: "Les is fantastic. He is brilliant, hardworking, genial, and ever available. He organizes a dozen attorneys who work on our IP matters, and always has a detailed understanding of the work he is supervising." Both partners currently handle prosecution and strategy for a number of companies, including a major medical device maker. Dinesh Melwani is another standout patent practitioner at the firm. In addition to his capabilities as a strategist to life sciences clients, he also has a focus on contentious proceedings as head of the firm's PTAB practice. He currently advises a leading biotechnology company on IP matters related to its therapeutic technologies.
Articles
Ceremony will take place on Sept. 18 at Essex House in New York